AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| IOP | 31 December 2017 Preliminary Report (Price Sensitive) | PRICE SENSITIVE | 11/04/18 | |
| IOP | Continued Suspension - failure to lodge audited Annual Financials - 31 December 2017 (Price Sensitive) | PRICE SENSITIVE | 03/04/18 | |
| IOP | 30 June 2017 Half Year Report (Price Sensitive) | PRICE SENSITIVE | 02/04/18 | |
| IOP | Continued Suspension - failure to lodge Preliminary Final Report - 31 December 2017 (Price Sensitive) | PRICE SENSITIVE | 19/03/18 | |
| IOP | Results of Annual General Meeting (Price Sensitive) | PRICE SENSITIVE | 19/03/18 | |
| IOP | AGM - Proxy Form | 01/03/18 | ||
| IOP | Notice of Meeting - AGM | 28/02/18 | ||
| IOP | 2017 Quarterly Reports (Price Sensitive) | PRICE SENSITIVE | 26/02/18 | |
| IOP 31 December 2017 Preliminary Report (Price Sensitive) | |||
| 11/04/18 | PRICE SENSITIVE | ||
| IOP Continued Suspension - failure to lodge audited Annual Financials - 31 December 2017 (Price Sensitive) | |||
| 03/04/18 | PRICE SENSITIVE | ||
| IOP 30 June 2017 Half Year Report (Price Sensitive) | |||
| 02/04/18 | PRICE SENSITIVE | ||
| IOP Continued Suspension - failure to lodge Preliminary Final Report - 31 December 2017 (Price Sensitive) | |||
| 19/03/18 | PRICE SENSITIVE | ||
| IOP Results of Annual General Meeting (Price Sensitive) | |||
| 19/03/18 | PRICE SENSITIVE | ||
| IOP AGM - Proxy Form | |||
| 01/03/18 | |||
| IOP Notice of Meeting - AGM | |||
| 28/02/18 | |||
| IOP 2017 Quarterly Reports (Price Sensitive) | |||
| 26/02/18 | PRICE SENSITIVE | ||
